This retrospective study has compared the outcomes of 3684 patients treated by radiofrequency ablation versus 296 patients treated by stereotactic body radiotherapy for localized hepatocellular carcinoma. After propensity matching, overall survival at 5 years was better after radiofrequency ablation (29.8%) than after stereotactic body radiotherapy (19.3%, P value <0.001).

(Rajyaguru DJ et al. – Journal of Clinical Oncology, 20 February 2018)

Read more